| 000 | 01753 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516080901.0 | ||
| 264 | 0 | _c20121009 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1476-5551 | ||
| 024 | 7 |
_a10.1038/leu.2012.53 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDaenen, S | |
| 245 | 0 | 0 |
_aIntensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. _h[electronic resource] |
| 260 |
_bLeukemia _cJul 2012 |
||
| 300 |
_a1726-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Letter; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _avan der Holt, B | |
| 700 | 1 | _aDekker, A W | |
| 700 | 1 | _aWillemze, R | |
| 700 | 1 | _aRijneveld, A W | |
| 700 | 1 | _aBiemond, B J | |
| 700 | 1 | _aMuus, P | |
| 700 | 1 | _avan de Loosdrecht, A A | |
| 700 | 1 | _aSchouten, H C | |
| 700 | 1 | _avan Marwijk Kooy, M | |
| 700 | 1 | _aBreems, D A | |
| 700 | 1 | _aDemuynck, H | |
| 700 | 1 | _aMaertens, J | |
| 700 | 1 | _aWijermans, P W | |
| 700 | 1 | _aWittebol, S | |
| 700 | 1 | _ade Klerk, E W | |
| 700 | 1 | _aCornelissen, J J | |
| 773 | 0 |
_tLeukemia _gvol. 26 _gno. 7 _gp. 1726-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/leu.2012.53 _zAvailable from publisher's website |
| 999 |
_c21567570 _d21567570 |
||